MediRX review
MediRx is a weight-loss telehealth storefront that white-labels OpenLoop Health's clinician network for actual prescribing and pharmacy fulfillment.
- Semaglutide
- $149/mo (starting dose, compounded)
- Tirzepatide
- $199/mo (starting dose, compounded)
- Coverage
- Coverage not published
- Brand-name
- Compounded only
Semaglutide · modeled / year
$1,788
Tirzepatide · modeled / year
$2,388
Pricing verified August 2026
The Index scorecard
MediRX scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- Publishes specific dollar pricing for both injection and oral-tablet forms of both drugs
- Rare self-disclosed distinction between promotional ($149) and standard ($179) semaglutide pricing
- LegitScript badge displayed on the page
- Genuine prescribing via OpenLoop Health's licensed clinician network, not a pure pass-through pharmacy
The tradeoffs
- MediRx itself has no named medical director -- all clinical care is outsourced to OpenLoop Health's network
- Tirzepatide's wide $199-$399 range makes the true likely monthly cost at a therapeutic dose unclear
- No specific compounding pharmacy is named beyond OpenLoop's unnamed 'partnered' pharmacies
- No states-served list found in accessible page content
The bottom line
Best for: Shoppers who want transparent published pricing and don't mind that prescribing is handled by a third-party clinician network (OpenLoop) rather than an in-house medical team. MediRx is a weight-loss telehealth storefront that white-labels OpenLoop Health's clinician network for actual prescribing and pharmacy fulfillment.
Ranked #339 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to MediRX.
- #315Tablet Health— Tablet Health is a LegitScript-certified DTC telehealth platform selling compounded semaglutide and tirzepatide in both oral-tablet and injectable form, priced from $179/mo (oral semaglutide) to $299/mo (injectable tirzepatide).57/100
- #316Alinwell— Alinwell markets compounded GLP-1s to women from $149 a month, but that figure is a first-month discount: the standing rates are $249 for semaglutide and $299 for tirzepatide, and neither appears until checkout.57/100
- #317Magnolia Regenerative Medicine— Magnolia Regenerative Medicine charges $119 a month for compounded semaglutide and $199 for tirzepatide once you reach the intake, advertises $99 and $179 that are really three-month prepay rates, and publishes a cancellation address that cannot receive mail.57/100
- #318Luvo Health— Publishes its entire 156-row price list before you touch an intake — then bills every one of those prices every four weeks, not every month, so a "year" here is thirteen charges rather than twelve.54/100
- #319WellMedr— Names its pharmacy, its clinician network and the FDA's compounding caveat right on the pricing page — then advertises two different "for life" rates on two live landers, quotes neither plan month-to-month, and bills on a cycle its own pages describe as four weeks in one place and 21 days in another.54/100
- #320ARSYNL Rx— ARSYNL Rx is a veteran-founded (Arron Glysch) telehealth platform selling compounded semaglutide ($233/mo) and tirzepatide, either as a standard injectable ($233/mo) or a needle-free HypoSpray with six dose protocols (from $256.33/mo).56/100
The 24 programs nearest this one
- #340 Mint Medical Clinic55
- #341 Nucore Health55
- #342 Optimized Health55
- #343 PeptidesRx55
- #344 Revive Meds55
- #345 Rivas Medical Weight Loss55
- #346 SkyRx55
- #347 TeleDocs36055
- #348 TelePeptide55
- #349 The Aesthetic Concierge55
- #350 The Virtual NP55
- #351 Fierce Health55
- #352 WeightCare54
- #353 BetterMe Rx54
- #354 Gatlan54
- #355 Iron Med RX54
- #356 Joey Med54
- #357 MANÜ Telehealth54
- #358 Medi-Weightloss54
- #359 Metaboost Rx54
- #360 Mirabel Meds54
- #361 NuBloom54
- #362 Pomegranate Health54
- #363 Rixa Health54
Pricing, states and verification reflect MediRX's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on MediRX's site. Not medical advice; see our disclosure.